Precision oncology for BRAF-mutant cancers with BRAF and MEK inhibitors: from melanoma to tissue-agnostic therapy

BRAF activation occurs as part of the mitogen-activated protein kinase (MAPK) cellular signaling pathway which leads to increased cellular proliferation and survival. Mutations in BRAF can result in unbridled activation of downstream kinases with subsequent uncontrolled cellular growth that formulat...

Descripción completa

Detalles Bibliográficos
Autores principales: Gouda, M.A., Subbiah, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984800/
https://www.ncbi.nlm.nih.gov/pubmed/36842301
http://dx.doi.org/10.1016/j.esmoop.2023.100788

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9984800/
https://www.ncbi.nlm.nih.gov/pubmed/36842301
http://dx.doi.org/10.1016/j.esmoop.2023.100788

Ejemplares similares